Clinical Pharmacology of MDA [3,4-methylenedioxyamphetamine]

California Pacific Medical Center Research Institute

Status: Completed

Conditions: Healthy

Treatments: Drug: Placebo; Drug: MDA

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00823407

5R01DA016776 (U.S. NIH Grant/Contract)

IND# 79,632

IRB# 27.112

27.112

CHR# H6637-31759-01

RAP-C# 0740

Details and patient eligibility

About

The purpose of this study is to investigate the pharmacological and cognitive effects of MDA in healthy humans.

Enrollment: 12 patients

Sex: All

Ages: 18 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy males and females age 18-50
• Fluent English speaker
• Willing and able to give written consent

Exclusion criteria

• Body mass index > 30 or < 18
• Pregnancy or lactation

FOR MORE DETAILS CONTACT THE RESEARCH CLINIC.

Trial design

Primary purpose: Basic Science

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Double Blind

---

12 participants in 1 patient group

MDA

Other group

Treatment:

Drug: MDA

Drug: Placebo